Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd

₹ 2,037 1.50%
14 Jun - close price
About

Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.

Key Points

Regional Leadership
KIMS is one of the largest corporate healthcare groups in Andhra Pradesh (AP) and Telangana in terms of the number of patients treated and treatments offered. It provides multidisciplinary integrated healthcare services, with a focus on primary, secondary & tertiary care in tier 2-3 cities and primary, secondary, tertiary, and quaternary healthcare in tier 1 cities. [1]

  • Market Cap 16,295 Cr.
  • Current Price 2,037
  • High / Low 2,357 / 1,600
  • Stock P/E 69.2
  • Book Value 233
  • Dividend Yield 0.00 %
  • ROCE 16.8 %
  • ROE 13.5 %
  • Face Value 10.0

Pros

Cons

  • Stock is trading at 8.73 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 11.6% over past five years.
  • Debtor days have increased from 37.0 to 44.4 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
257 332 284 273 254 263 292 284 293 299 316 302 305
172 220 186 174 166 185 204 194 189 207 218 215 219
Operating Profit 84 111 98 99 88 78 88 90 104 92 98 87 86
OPM % 33% 34% 35% 36% 35% 30% 30% 32% 36% 31% 31% 29% 28%
4 4 9 3 8 4 8 7 4 4 4 4 4
Interest 3 2 1 1 1 0 0 0 0 0 0 1 2
Depreciation 11 11 11 11 11 11 11 11 11 12 13 13 20
Profit before tax 74 102 95 90 84 70 84 86 97 84 89 78 67
Tax % 29% 25% 25% 25% 24% 26% 27% 25% 24% 25% 26% 25% 29%
53 76 71 67 64 52 61 64 74 63 66 58 48
EPS in Rs 6.84 9.52 8.91 8.37 7.99 6.51 7.65 8.06 9.20 7.83 8.27 7.29 6.02
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
485 536 628 707 790 933 1,143 1,132 1,222
380 422 562 652 584 624 740 769 858
Operating Profit 104 114 66 55 206 309 403 363 364
OPM % 22% 21% 10% 8% 26% 33% 35% 32% 30%
4 3 3 6 7 8 21 24 16
Interest 36 32 88 33 24 18 9 5 4
Depreciation 34 34 38 41 43 45 45 45 58
Profit before tax 38 51 -57 -13 147 254 371 337 318
Tax % 37% 37% -43% -225% 17% 26% 25% 25% 26%
24 33 -81 -44 121 189 278 252 235
EPS in Rs 3.45 4.54 -11.35 -5.86 16.26 24.31 34.78 31.55 29.41
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 12%
3 Years: 9%
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: 49%
3 Years: 7%
TTM: -7%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 27%
Return on Equity
10 Years: %
5 Years: 19%
3 Years: 17%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 70 72 50 74 74 78 80 80 80
Reserves 191 252 -249 429 549 830 1,298 1,551 1,786
251 277 666 187 186 131 18 4 326
134 153 323 166 148 175 173 177 204
Total Liabilities 646 753 789 857 957 1,214 1,569 1,812 2,397
498 501 576 567 559 582 592 612 674
CWIP 2 64 0 0 2 8 13 16 292
Investments 18 22 31 80 178 213 542 826 1,001
128 167 182 210 218 411 422 358 430
Total Assets 646 753 789 857 957 1,214 1,569 1,812 2,397

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
89 78 94 109 161 291 284 270 262
-39 -99 -52 -99 -108 -317 -375 -237 -569
-61 25 -42 -12 -24 25 76 -15 289
Net Cash Flow -10 5 0 -2 28 0 -15 18 -18

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 46 59 56 52 46 29 28 39 44
Inventory Days 35 43 39 42 44 30 38 30 32
Days Payable 192 205 189 161 158 155 118 112 114
Cash Conversion Cycle -111 -103 -94 -68 -68 -96 -52 -44 -38
Working Capital Days 11 26 -72 7 -2 -4 10 13 42
ROCE % 15% 6% 3% 23% 30% 31% 23%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
38.84% 38.84% 38.84% 38.84% 38.84% 38.85% 38.85% 38.85% 38.85% 38.85% 38.82% 38.82%
11.57% 9.90% 8.44% 8.91% 8.36% 10.17% 20.50% 19.41% 13.15% 14.24% 15.27% 16.73%
16.28% 18.64% 20.87% 21.02% 22.78% 27.97% 28.32% 29.76% 35.77% 34.80% 34.24% 33.13%
33.31% 32.61% 31.84% 31.23% 30.01% 23.01% 12.34% 11.99% 12.23% 12.10% 11.67% 11.32%
No. of Shareholders 1,03,05786,38974,35573,66470,79567,73563,36260,98065,44966,95771,01469,092

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls